{"id":"https://openalex.org/W44219944","doi":null,"title":"Immune responses to human tumors: development of tumor vaccines.","display_name":"Immune responses to human tumors: development of tumor vaccines.","alternate_titles":[],"publication_year":2003,"publication_date":"2003-05-01","ids":{"openalex":"https://openalex.org/W44219944","mag":"44219944","pmid":"https://pubmed.ncbi.nlm.nih.gov/12894571"},"language":"en","primary_location":{"id":"pmid:12894571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12894571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W44219944"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030021861","display_name":"Chris D. Platsoucas","orcid":"https://orcid.org/0000-0002-9617-8991","observed_orcids":["https://orcid.org/0000-0002-9617-8991"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris D Platsoucas","raw_affiliation_strings":["Department of Microbiology and Immunology, School of Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA. chris.platsoucas@temple.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, School of Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA. chris.platsoucas@temple.edu","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067827079","display_name":"John E. Fincke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John E Fincke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031959056","display_name":"John Pappas","orcid":"https://orcid.org/0000-0001-5625-2598","observed_orcids":["https://orcid.org/0000-0001-5625-2598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Pappas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029979891","display_name":"Weon-Ju Jung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weon-Ju Jung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052810442","display_name":"Mark C. Heckel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Heckel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008107387","display_name":"Roland Schwarting","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roland Schwarting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048961308","display_name":"Eleni E. Magira","orcid":"https://orcid.org/0000-0002-4430-7886","observed_orcids":["https://orcid.org/0000-0002-4430-7886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eleni Magira","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072539940","display_name":"Dimitri S. Monos","orcid":"https://orcid.org/0000-0003-4065-0908","observed_orcids":["https://orcid.org/0000-0003-4065-0908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dimitri Monos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113728890","display_name":"Ralph S. Freedman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralph S Freedman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8684,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.84912082,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"23","issue":"3A","first_page":"1969","last_page":"1996"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.843999981880188},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.5529999732971191},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.6890000104904175},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.5009999871253967},{"id":"https://openalex.org/keywords/hla-class-i-downregulation","display_name":"HLA class I downregulation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/altered-peptide-ligands","display_name":"altered peptide ligands","score":0.8399999737739563},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.859000027179718},{"id":"https://openalex.org/keywords/immunosuppressive-cytokines","display_name":"immunosuppressive cytokines","score":0.9620000123977661},{"id":"https://openalex.org/keywords/fas-fasl-pathway","display_name":"Fas/FasL pathway","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9049999713897705},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/dendritic-cell-antigen-presentation","display_name":"dendritic cell antigen presentation","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.784758448600769},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6757090091705322},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6248688697814941},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5686567425727844},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5605489015579224},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5187640190124512},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.5013494491577148},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4901064336299896},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.48339739441871643},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.4829794466495514},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14505454897880554},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07612809538841248}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016233","descriptor_name":"Immunotherapy, Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12894571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12894571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:44219944","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12894571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1139252554","display_name":"AUTOLOGOUS TUMOR SPECIFIC TIL IN MELANOMA","funder_award_id":"R01CA052308","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4539334178","display_name":"TRAINING PROGRAMS IN MICROBIOLOGY AND IMMUNOLOGY","funder_award_id":"T32AI007101","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6240361247","display_name":"TUMOR-SPECIFIC ANTIGEN(S) IN HUMAN OVARIAN CARCINOMA","funder_award_id":"R01CA057884","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7200683994","display_name":"OVARIAN CARCINOMA TIL TREATMENT AFTER IFN GAMMA/IL2","funder_award_id":"R01CA064943","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2488733883","https://openalex.org/W2354892664","https://openalex.org/W2154439237","https://openalex.org/W2094358946","https://openalex.org/W2059494039","https://openalex.org/W2020847109","https://openalex.org/W2108011071","https://openalex.org/W2135597594","https://openalex.org/W2568723186","https://openalex.org/W2317243518"],"abstract_inverted_index":{"Strong":[0],"evidence":[1,41],"has":[2,143,371,413],"been":[3,144,174,372,414],"accumulated":[4],"demonstrating":[5],"that":[6,199,310],"tumor":[7,62,70,90,129,138,147,190,201,225,230,237,248,274,302,327,335,356,367,406,428],"cells":[8,63,66,79,202,275],"in":[9,15,117,155,166,185,292,333,352,374,397],"humans":[10],"and":[11,23,49,86,92,146,162,180,208,266,296,408,426,430],"animal":[12],"are":[13,25,203,331],"recognized":[14],"general":[16],"as":[17,264,342],"non-self":[18],"by":[19,210,247,273],"the":[20,68,74,84,107,111,123,132,160,171,196,200,211,222,277,324,353,361,364,403],"immune":[21,30,102,115,212,391],"system":[22],"they":[24,330],"able":[26],"to":[27,35,60,65,168,182,187,205,319,360,419,423],"induce":[28],"an":[29,390],"response":[31,392],"which":[32,57,99],"often":[33],"leads":[34],"their":[36],"elimination.":[37],"In":[38,358],"humans,":[39],"this":[40],"includes:":[42],"(a)":[43],"The":[44,120,298,399],"development":[45,133,306,325,354,365,404],"of":[46,76,89,93,113,126,134,151,159,170,216,224,229,235,241,252,260,270,285,300,326,355,366,378,405],"T-cell":[47],"lines":[48],"clones":[50],"with":[51],"antitumor":[52],"activity":[53],"(cytotoxic":[54],"or":[55,64,136,233,283,290,315],"helper)":[56],"is":[58,307],"restricted":[59],"autologous":[61],"expressing":[67],"same":[69],"peptide/HLA":[71],"epitope;":[72],"(b)":[73],"presence":[75,112],"oligoclonal":[77],"T":[78],"infiltrating":[80],"many":[81],"tumors;":[82],"(c)":[83],"identification":[85],"molecular":[87],"cloning":[88],"antigens":[91,130,303,317],"peptides":[94],"derived":[95],"from":[96,195],"these":[97],"antigens,":[98],"elicit":[100],"HLA-restricted":[101],"responses.":[103],"Their":[104],"discovery":[105],"provided":[106],"ultimate":[108],"proof":[109],"for":[110,122,304,323,338,410],"specific":[114,314],"responses":[116,154,165],"human":[118],"tumors.":[119],"availability":[121],"first":[124],"time":[125],"molecularly":[127],"cloned":[128],"permitted":[131],"peptide":[135,148,245],"recombinant":[137],"vaccines.":[139,191,357],"Although":[140],"significant":[141],"progress":[142,362,370,400],"made":[145,373,401],"vaccines":[149,328,407,429],"capable":[150],"eliciting":[152],"biological":[153],"more":[156],"than":[157],"50%":[158],"patients":[161,172],"objective":[163],"clinical":[164],"10":[167],"42%":[169],"have":[173],"reported,":[175],"certain":[176],"major":[177],"problems":[178,193],"remain":[179],"need":[181,418],"be":[183,320,387,395,420],"resolved":[184],"order":[186],"develop":[188,424],"effective":[189,388,427],"These":[192],"emanate":[194],"following":[197],"mechanisms":[198],"employing":[204],"avoid":[206],"detection":[207],"destruction":[209],"system:":[213],"(i)":[214],"Down-regulation":[215,228,282],"HLA":[217],"class":[218],"I":[219],"expression":[220,232],"on":[221,255,382],"surface":[223],"cells;":[226,249,257],"(ii)":[227],"antigen":[231,339],"selection":[234,299],"negative":[236],"variants;":[238],"(iii)":[239],"Expression":[240],"naturally":[242],"occurring":[243],"altered":[244],"ligands":[246],"(iv)":[250],"Lack":[251],"costimulatory":[253],"molecules":[254],"tumors":[256],"(v)":[258],"Production":[259],"immunosuppressive":[261],"cytokines,":[262],"such":[263,341],"TGF-beta":[265],"IL-10;":[267],"(vi)":[268],"Induction":[269],"lymphocyte":[271],"apoptosis":[272],"using":[276,344],"Fas/Fas":[278],"L":[279],"pathway;":[280],"(vii)":[281],"absence":[284],"CD3":[286],"zeta":[287],"(zeta)":[288],"transcripts":[289],"protein":[291],"tumor-infiltrating":[293],"lymphocytes":[294],"(TIL),":[295],"others.":[297],"optimal":[301],"vaccine":[305],"another":[308],"issue":[309],"requires":[311],"attention.":[312],"Lineage":[313],"differentiation":[316],"appear":[318],"better":[321],"candidates":[322],"because":[329],"expressed":[332],"all":[334],"cells.":[336],"Methods":[337],"presentation,":[340],"those":[343],"dendritic":[345],"cells,":[346],"also":[347],"play":[348],"a":[349],"critical":[350],"role":[351],"addition":[359],"towards":[363,402],"vaccines,":[368],"substantial":[369],"developing":[375],"advanced":[376],"methods":[377],"adoptive":[379,411,431],"immunotherapy":[380,412,432],"based":[381],"TIL.":[383],"This":[384],"approach":[385],"can":[386,393],"when":[389],"not":[394],"elicited":[396],"vivo.":[398],"approaches":[409],"substantial.":[415],"Additional":[416],"studies":[417],"carried":[421],"out":[422],"new":[425],"methods.":[433]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W44219944","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
